Is Regeneron Pharmaceuticals, Inc.'s (NASDAQ:REGN) Stock's ...

Yahoo Finance - 29 Mar 2024
Most readers would already know that Regeneron Pharmaceuticals' (NASDAQ:REGN) stock increased by 9.6% over the past...

Regeneron Pharmaceuticals, Inc. (REGN): Among the Most Promising Cancer Stocks According to Hedge Funds

Yahoo Finance - 23 Nov 2024
Regeneron Pharmaceuticals, Inc. (REGN): Among the Most Promising Cancer Stocks According to Hedge Funds ...

Regeneron: The Biotech Stock To Buy Now (NASDAQ:REGN)

Seeking Alpha - 19 Nov 2024
Regeneron: The Biotech Stock To Buy Now (NASDAQ:REGN) ...

Here’s Why Regeneron Pharmaceuticals (REGN) Declined in Q3

Yahoo Finance - 19 Nov 2024
Here’s Why Regeneron Pharmaceuticals (REGN) Declined in Q3 ...

Regeneron Pharmaceuticals, Inc.'s (NASDAQ:REGN) Price Is Out Of Tune With Earnings

Simply Wall St - 22 Nov 2024
Regeneron Pharmaceuticals, Inc.'s (NASDAQ:REGN) Price Is Out Of Tune With Earnings ...

Regeneron (REGN) to Present at Two Major Healthcare Investor Conferences | REGN Stock News

StockTitan - 11 Nov 2024
Regeneron (REGN) to Present at Two Major Healthcare Investor Conferences | REGN Stock News ...

Pacer Advisors Inc. Acquires 3,076 Shares of Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN)

MarketBeat - 23 Nov 2024
Pacer Advisors Inc. Acquires 3,076 Shares of Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) ...

(REGN) On The My Stocks Page

Stock Traders Daily - 21 Nov 2024
(REGN) On The My Stocks Page ...

Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces Investigation of Regeneron Pharmaceuticals, Inc. (REGN) on Behalf of Investors

Business Wire - 04 Nov 2024
Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces Investigation of Regeneron Pharmaceuticals, Inc. (REGN) on Behalf of Investors ...

Regeneron Pharmaceuticals, Inc. (REGN): Among the Best Genomics Stocks to Buy Right Now

Yahoo Finance - 19 Nov 2024
Regeneron Pharmaceuticals, Inc. (REGN): Among the Best Genomics Stocks to Buy Right Now ...

FDA Accepts SNY and REGN's Dupixent Re-Submitted sBLA for Urticaria

MSN - 24 Nov 2024
FDA Accepts SNY and REGN's Dupixent Re-Submitted sBLA for Urticaria ...

Regeneron Pharmaceuticals (NASDAQ:REGN) shareholders have earned a 15% CAGR over the last five years

Yahoo Finance - 23 Nov 2024
Regeneron Pharmaceuticals (NASDAQ:REGN) shareholders have earned a 15% CAGR over the last five years ...

Is Weakness In Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) Stock A Sign That The Market Could be Wrong Given Its Strong Financial Prospects?

Yahoo Finance - 05 Nov 2024
Is Weakness In Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) Stock A Sign That The Market Could be Wrong Given Its Strong Financial Prospects? ...

NASDAQ: REGN Lawsuit Against Directors Pending - Investors Who Hold Shares of Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) Long Should Contact the Shareholders Foundation

Newswire - 10 Sep 2024
NASDAQ: REGN Lawsuit Against Directors Pending - Investors Who Hold Shares of Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) Long Should Contact the Shareholders Foundation ...

REGN